An Efficacy Study of Chlorhexidine Mouthwashes

Phase 4

Completed

• Conditions: Gingivitis
• Interventions: Drug: Chlorhexidine Digluconate Mouthwash with Alcohol; Drug: Chlorhexidine Digluconate Mouthwash without Alcohol

• Registration Number: NCT01751178
• Lead Sponsor: GlaxoSmithKline

Brief Summary

The aim of this study is to compare subject gingival health after 6 weeks of twice daily use of a non-alcohol or alcohol containing mouthrinse and brushing compared to brushing only.

Detailed Description

Not available

Study Timeline

• Study Start: 2012-10
• Study First Submitted: 2012-12-13
• Study First Submitted QC: 2012-12-13
• Study First Posted: 2012-12-17
• Primary Completion: 2013-03
• Study Completion: 2013-03
• Results First Submitted: 2014-05-01
• Status Verified: 2014-06
• Results First Submitted QC: 2014-07-03
• Last Update Submitted: 2014-07-03
• Results First Posted: 2014-07-28
• Last Update Posted: 2014-07-28

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 324

Inclusion Criteria

• Good general health with (in the opinion of the investigator) no clinically significant and relevant abnormalities of medical history or oral/ dental examination.

  5. a) Good oral health in the opinion of the investigator (allowing mild to moderate gingivitis to meet entry criteria).

  b) A minimum of 20 permanent gradable teeth at screening. (Gradable teeth are those where restorative materials cover less than 25% of the tooth surface graded).

  c) Mild to moderate gingivitis present at the screening visit in the opinion of the investigator.

  d) Positive response to bleeding on brushing exercise at screening visit. e) A total of 20 bleeding sites or greater at baseline visit.

Exclusion Criteria

• Known or suspected intolerance or hypersensitivity to Chlorhexidine or other study materials (or closely related compounds) or any of their stated ingredients.

• 5. a) Current or relevant history of any serious, severe or unstable physical or psychiatric illness or any other medical condition (e.g. Diabetes Mellitus) that would make the subject unlikely to fully complete the study or any that increases the risk to the subject or undermines the data validity.

  b) Subjects requiring prophylactic antibiotic treatment prior to dental therapy.

  c) Use of concomitant medication that, in the opinion of the investigator, might interfere with the outcome of the study or increases the risk to the subject (eg: phenytoin, calcium antagonists, cyclosporine, warfarin, antibiotics, immuno-suppressants).

  d) Use of antibiotics within two weeks prior to the screening visit or throughout the study.

  e) Use of any systemic medication which would have an effect on gingival conditions within 14 days of gingival examinations (eg: ibuprofen or aspirin therapy) 6. a) Have current active caries b) More than 3 pockets with 5mm or over. c) Excessive calculus present that interferes with the probing examination for Gingival Index.

  d) Other severe oral/ gingival conditions (e.g. Acute Necrotizing Ulcerative Gingivitis) that may compromise the study or the subjects in the opinion of the investigator or gingivitis examiner.

  e) Medical conditions which may directly influence gingival bleeding. f) Restorations in a poor state of repair. g) Orthodontic appliances anterior cosmetic restorations and veneers. h) Enamel pitting/irregularities. 7. Subjects using chewing tobacco, pan, pan-masala, gutkha or other chewing tobacco products or subjects who have quit using any of those within the past six months prior to screening.

  8. b) An employee of any toothpaste manufacturer or their immediate family.

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Mouthwash with Alcohol	Chlorhexidine Digluconate Mouthwash with Alcohol	rinse with 10ml 0.2% w/v Chlorhexidine Digluconate Mouthwash with alcohol for 1 timed minute twice daily for 6 weeks following brushing with a full brush head of standard toothpaste for 1 timed minute.
Mouthwash without Alcohol	Chlorhexidine Digluconate Mouthwash without Alcohol	rinse with 10ml 0.2% w/v Chlorhexidine Digluconate Mouthwash without alcohol for 1 timed minute twice daily for 6 weeks following brushing with a full brush head of standard toothpaste for 1 timed minute.

Primary Outcome Measures

Name	Time	Method
Gingival Severity Index (GSI) Based on the Gingival Index (GI)	Change from baseline to 6 weeks	Measure of gingival severity averaged across whole mouth site; each site scored 0, 1, 2, 3 based on GI and,; 1. GSI = 0 if GI is 0 or 1 (no bleeding); 2. GSI = 1 if GI is 1 or 2 (bleeding)

Secondary Outcome Measures

Name	Time	Method
Gingival Index	Change from baseline to 6 weeks	The GI was assessed on the facial and lingual surfaces at six sites on each tooth (facial and lingual - distal papillae, margin and mesial papillae). These assessments were performed on all evaluable teeth using moderate pressure sweeping a blunt ended probe, which was engaged in approximately 1 millimetre (mm) into the gingival crevice. The scores could range from 0-3 (0=Absence of inflammation; 1=Mild Inflammation-Slight change in color slight change in texture, no bleeding on probing; 2=Moderate Inflammation -glazing, redness edema and hypertrophy, bleeding on probing; 3= Severe inflammation-marked redness and hypertrophy, tendency for spontaneous bleeding)
Turesky Modification of Quigley & Hein Plaque Index for Overall Plaque Scores	Change from baseline to 6 weeks	Overall plaque scores were calculated taking the average over all tooth sites for a participant. The scores could range from 0-5 (0=No plaque; 1=Slight flecks of plaque at the cervical margin of the tooth; 2= A thin continuous band of plaque (1 mm or smaller) at the cervical margin of the tooth; 3=A band of plaque wider than 1 mm but covering less than 1/3 of the area to be graded of the crown of the tooth; 4=Plaque covering at least 1/3 but less than 2/3 of the area to be graded of the crown of the tooth; 5=Plaque covering 2/3 or more of the area to be graded of the crown of the tooth)
Turesky Modification of Quigley & Hein Plaque Index for Interproximal Plaque Scores	Change from baseline to 6 weeks	Interproximal plaque scores were analyzed on the mesiofacial, distofacial, mesiolingual and distolingual surfaces, and calculated taking the average over all tooth sites for a participant. The scores could range from 0-5 (0=No plaque; 1=Slight flecks of plaque at the cervical margin of the tooth; 2= A thin continuous band of plaque (1 mm or smaller) at the cervical margin of the tooth; 3=A band of plaque wider than 1 mm but covering less than 1/3 of the area to be graded of the crown of the tooth; 4=Plaque covering at least 1/3 but less than 2/3 of the area to be graded of the crown of the tooth; 5=Plaque covering 2/3 or more of the area to be graded of the crown of the tooth)

Trial Locations

Locations (3)

Intertek 4-Front Research - Widnes; 🇬🇧 Widnes, Cheshire, United Kingdom

Intertek - Manchester Science Park; 🇬🇧 Manchester, United Kingdom

4Front, Ellesmere Port; 🇬🇧 Cheshire, United Kingdom